GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Access Bio Inc (XKRX:950130) » Definitions » Cash Flow for Lease Financing

Access Bio (XKRX:950130) Cash Flow for Lease Financing : ₩-6,131 Mil (TTM As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Access Bio Cash Flow for Lease Financing?

Access Bio's Cash Flow for Lease Financing for the three months ended in Sep. 2024 was ₩-1,492 Mil. Access Bio's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Sep. 2024 was ₩-6,131 Mil.

Compared with last quarter (₩-1,790 Mil in Jun. 2024 ), Access Bio's Cash Flow for Lease Financing increased in Sep. 2024 (₩-1,492 Mil).


Access Bio Cash Flow for Lease Financing Historical Data

The historical data trend for Access Bio's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Access Bio Cash Flow for Lease Financing Chart

Access Bio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -747.36 -741.94 -2,240.77 -4,481.77 -6,332.68

Access Bio Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,818.10 -1,169.89 -1,679.40 -1,789.67 -1,492.11

Access Bio Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-6,131 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Access Bio Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Access Bio's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Access Bio Business Description

Traded in Other Exchanges
N/A
Address
65 Clyde Road, Suite A, Somerset, NJ, USA, 08873
Access Bio Inc is a United States based bio company engaged in the research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. The products are for the prevention and early diagnosis of infectious diseases. The company's core in vitro-diagnostic technology includes immunochemical, biochemical and molecular products. The company offers products for Rapid Diagnostic Tests including CareStart G6PD RDT, CareStart Malaria, CareStart Dengue Combo, and CareStart Scrub Typhus IgM; Biosensors product includes CareStart G6PD Biosensor, and Molecular Diagnostics products include CareStart HPV and CareStart CAH.

Access Bio Headlines

No Headlines